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Hyaluronan prevents the decreased net ultrafiltration caused by in-
creased peritoneal dialysate fill volume. In the present study, we investi-
gated (1) the effect of an increase in dialysate fill volume on peritoneal
fluid and solute transport using a 1.36% glucose solution, and (2) the
effect of intraperitoneal administration of hyaluronan on peritoneal
transport characteristics when different fill volumes were used. A four-
hour dwell study with frequent dialysate and blood sampling was per-
formed in 26 male Sprague-Dawley rats with 131I albumin as the intra-
peritoneal volume marker. Each rat was injected intraperitoneally with 25
ml (group Con25, N 5 6) or 40 ml (group Con40, N 5 7) of 1.36% glucose
dialysis solution alone or 25 ml (group HA25, N 5 6) or 40 ml (Group
HA40, N 5 7) of 1.36% glucose dialysis solution with 0.01% hyaluronan.
The peritoneal transport of fluid, glucose, urea, and total protein as well
as the intraperitoneal hydrostatic pressure (IPP) with different fill volumes
were evaluated. We found that IPP and peritoneal fluid absorption rate
significantly increased with the increase in fill volume (P , 0.01), and
therefore the net ultrafiltration volume was significantly lower in the
Con40 group compared to the Con25 group despite a higher transcapillary
ultrafiltration rate in the Con40 group. The addition of hyaluronan to
dialysate significantly (P , 0.01) decreased the peritoneal fluid absorption
rate (by 22% in HA25 vs. Con25 and by 29% in HA40 vs. Con40) and thus
significantly increased the net peritoneal fluid removal. The diffusive mass
transport coefficients for glucose, urea and total protein did not differ
between the Con25 and Con40 groups or between the two hyaluronan
groups as compared to their respective control groups. The peritoneal
clearance of urea increased significantly in the high fill volume group (by
58% in Con40 vs. Con25) and in the two hyaluronan groups (by 21% in
HA25 vs. Con25 and by 16% in HA40 vs. Con40). We conclude that: (1)
An increase in dialysate fill volume using 1.36% glucose dialysis solution
results in higher intraperitoneal hydrostatic pressure and higher perito-
neal fluid absorption rate, and therefore lower net ultrafiltration. (2)
Intraperitoneal addition of hyaluronan significantly decreases the perito-
neal fluid absorption rate, and the decreasing effect is even more marked
when a high fill volume is used. (3) Small solute clearances increase
markedly with increases in fill volume, and then further increase by adding
hyaluronan to the dialysate due to the increase in drainage volume. Thus,
intraperitoneal administration of hyaluronan during a single peritoneal
dialysis exchange may significantly increase the peritoneal fluid and solute
removal by decreasing peritoneal fluid absorption, and may thereby
prevent the decreased net ultrafiltration caused by an increase in dialysate
fill volume.
It has recently been recommended that the dialysate fill volume
be increased from 2 liters to 2.5 liters or 3 liters to achieve
adequate peritoneal dialysis in all patients, especially in large,
anuric patients [1]. However, it has been demonstrated that
increases in intraperitoneal volume would increase the intraperi-
toneal hydrostatic pressure (IPP) [2, 3]. This increase in IPP
consequently increased peritoneal fluid absorption [3, 4]. In fact,
several studies found that increased IPP is associated with poor
fluid removal (decreased net ultrafiltration volume) [5–8]. Thus,
great concerns have surfaced about the possible decrease in net
ultrafiltration volume due to increased fluid absorption rate
associated with high fill volume and high intraperitoneal hydro-
static pressure [9–11]. We have previously reported that the
decreased net ultrafiltration volume associated with higher fill
volume (due to higher IPP and higher peritoneal fluid absorption)
could be avoided if hypertonic (3.86%) glucose solutions are used
[3]. However, the use of hypertonic glucose solution may be
limited by their adverse side effects [12]. In fact, dialysis fluid with
low glucose concentration is the most commonly used solution.
Krediet et al found that the net ultrafiltration using 1.36% glucose
dialysis solution was significantly lower in the 3 liter group
compared to the 2 liter group during a four-hour dwell study,
mainly due to an increase in peritoneal fluid absorption in the 3
liter solution group [13]. Therefore, reducing the peritoneal fluid
absorption should be a conceivable and potentially effective way
to improve the adequacy (as regards to the removal of both small
solutes and fluid) of peritoneal dialysis, especially when high fill
volumes are used.
Hyaluronan is a long polysaccharide chain that is made up of
repeating disaccharide units of N-acetylglucosamine and glucu-
ronic acid. Hyaluronan is found in most tissues in the body [14, 15]
and in the drainage dialysis fluid during peritoneal dialysis [16,
17]. Hyaluronan plays an important role in tissue hydraulic
conductivity. It has been shown that hyaluronan exhibits a high
resistance against water flow and can thus act in tissue as a barrier
against rapid changes in water content [18–20]. In the intersti-
tium, hyaluronan decreases the water permeability of the mem-
brane [21, 22]. In a previous study, we have demonstrated that
adding 0.01% hyaluronan to peritoneal dialysis fluid in rats could
increase the peritoneal fluid removal mainly by decreasing the
peritoneal fluid absorption, resulting in increased peritoneal urea
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clearance [23]. We speculated that the observed effect of hyalu-
ronan on peritoneal fluid absorption may be due to the accumu-
lation of a restrictive filter “cake” of hyaluronan chains at the
tissue-cavity interface [23]. As peritoneal fluid absorption is
mainly driven by IPP, it is conceivable that raising IPP would
transiently increase convective transport into the boundary,
thereby raising the concentration and thickness of the hyaluronan
layer, which could increase the resistance of the outflow of fluid
from the peritoneal cavity. If such effects on peritoneal fluid
absorption could be demonstrated by an addition of hyaluronan to
peritoneal dialysis fluid, it could conceivably improve the effi-
ciency (both regarding fluid and solute removal) of peritoneal
dialysis with increased dialysate fill volume, especially when using
low glucose (1.36%) solution.
In this study, we made a detailed investigation of peritoneal
fluid kinetics and solute transport in rats receiving different
dialysate fill volumes using 1.36% glucose solution. In the second
part of the study, we then made a detailed analysis of the effect of
intraperitoneal hyaluronan on the peritoneal fluid and solute
transport characteristics in rats when the different fill volumes
were used.
METHODS
Twenty-six male Sprague-Dawley rats with an average body wt
of 290 g (range 280 to 300 g) were divided into four groups. Each
rat was anesthetized with a single intraperitoneal injection of 50
mg/kg pure pentobarbital sodium (Pharmacia, Sweden). This
anesthesia was reported not to alter the peritoneal transport in
rats [9]. The fur over the abdominal wall was clearly shaved. The
animal was laid in a supine position and was kept at 37°C with a
heating pad (CMN/Microdialysis, Stockholm, Sweden). Isotonic
saline, 1 ml/hour, was injected subcutaneously to prevent hypovo-
lemia. A multiholed silastic catheter (Venoflon, 0.8 mm internal
diameter; Helsingborg, Sweden) was inserted percutaneously in
the left lower quadrant of the abdomen for dialysis fluid infusion
and sampling. The experiment was started by giving an intraperi-
toneal injection of 25 ml (group Con25, N 5 6) or 40 ml (group
Con40, N 5 7) of sterile 1.36% glucose dialysis fluid. In the other
two groups, 0.01% sterile hyaluronan (protein and endotoxin free;
average molecular wt 500,000; Hyal, Toronto, Canada) was added
to 25 ml (group HA25, N 5 6) or 40 ml (Group HA40, N 5 7) of
sterile 1.36% glucose dialysis fluid. This concentration of hyalu-
ronan has been shown to protect the hyaluronan layer around the
human peritoneal methothelial cells [24] and the peritoneum
from injury caused by saline infusion [25], as well as to effectively
decrease the peritoneal fluid absorption [23]. All the fluids were
prewarmed to 37°C and mixed with 18.5 kBq 131I-human serum
albumin (RISA; Isopharma AS, Kjeller, Norway). A small dose
(0.2 g/liter) of human albumin was added to the solution to
minimize adhesion of tagged albumin to the surface of the
catheter. The solution was administered via a three-way valve
(Viggo, Connecta, Helsingborg, Sweden) and the catheter, over a
period of about one minute, and allowed to remain in the
peritoneal cavity for four hours. The intraperitoneal hydrostatic
pressure was measured after the infusion using a water manom-
eter connected to the peritoneal catheter, setting the reference
level at the heart of the rat. Dialysate samples (0.4 ml) were taken
at 0, 3, 15, 30, 60, 90, 120, 180 and 240 minutes after the dialysis
fluid had been infused. Prior to each sampling, 1 ml of the
dialysate was flushed back and forth five times through the
catheter. Blood samples were drawn at 0, 120 and 240 minutes
from the tail artery. After 240 minutes, the peritoneal cavity was
opened and the dialysate was collected using a syringe and
preweighted gauze tissue.
Dialysate samples (0.1 ml) and blood samples (0.1 ml of
plasma) were analyzed for RISA activity on a Gamma Counter
(Packard Instrument Company, Meriden, CT, USA) for 10 min-
utes each. Dialysate and plasma concentrations of urea (urease-
glutamate dehydrogenase method), protein (Coomassie Brilliant
Blue dye binding method) and glucose concentration (hexokinase
method) were analyzed using a Multistat Autoanalyzer (Instru-
mentation Laboratory, Spokane, WA, USA).
The intraperitoneal dialysate volume was estimated from the
dilution of RISA with corrections made for the elimination of the
RISA from the peritoneal cavity. The total peritoneal fluid
absorption rate as assessed by RISA elimination coefficient (KE
ml/min) was calculated as described previously [26, 27]. The
intraperitoneal volume change (net ultrafiltration) at time t was
calculated as the intraperitoneal volume at time t (Vt) minus the
infused volume (V0). The transcapillary ultrafiltration rate (Qu)
was defined as the rate of intraperitoneal volume change plus the
rate of fluid absorption (KE) [27]. The direct lymphatic absorption
of fluid from peritoneal cavity was assessed as the RISA elimina-
tion rate from the peritoneal cavity to the blood (KEB ml/min).
The KEB was calculated from the rate of increase of RISA amount
in plasma divided by the average intraperitoneal RISA concen-
tration [8]. The plasma volume was set at 3.6 ml/100 g body wt [8].
The remaining part of fluid absorption to the peritoneal tissue
interstitium and capillaries (KET ml/min), was calculated as KE
minus KEB.
The dialysate-to-plasma-solute concentration ratios (D/P) for
all the investigated solutes were calculated by dividing the dialy-
sate concentration of a solute at a certain time with the aqueous
concentration of the investigated solute in plasma [28]. If no blood
sample was taken at the same time as a dialysate sample, then the
blood concentration of solute was linearly interpolated from the
blood sample taken before and after this moment [29]. The D/D0
for glucose was calculated as the dialysate glucose concentration
(D) divided by the glucose concentration in the fresh dialysis
solution (D0). The clearance of the investigated solutes was
calculated as the total amount of the solute in the drained
dialysate at 240 minutes minus the infused amount and divided by
the mean blood concentration of the solute and the dwell times.
The diffusive mass transport coefficients (KBD, ml/min) were
estimated using the modified Babb-Randerson-Farrell (BRF)
model as described previously [30, 31]. The model describes the
net change of the solute amount in peritoneal dialysate over time
increment equal to the rate of solute flow between blood and
dialysate due to combined diffusion, convective transport, and
peritoneal absorption of the solute. In addition, in this study, we
set the sieving coefficients (S) for glucose and urea to 0.55 and for
total protein to 0.05 based on previous studies [3, 32].
Two-way ANOVA with repeated measurements and one-way
ANOVA were applied to compare intraperitoneal volume, ultra-
filtration rate, KE, KEB, KET, D/P ratios, and KBD. When
ANOVA showed a significant difference among the four groups,
then Scheffe’s F-test was used to compare the difference between
different groups. Special attention was paid to compare the results
between the Con25 group and the Con40 group, between the
Con25 and the HA25 groups, and between the Con40 and the
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HA40 groups using the unpaired Student’s t-test. The results are
expressed as mean 6 SD. A P value of less than 0.05 was
considered significant.
RESULTS
Fluid transport
Fluid transport characteristics are shown in Figures 1 and 2 and
Table 1. The increase in dialysate fill volume resulted in a
significant increase (P , 0.01) in intraperitoneal hydrostatic
pressure (IPP) from 1.7 6 0.5 cm H2O in the Con25 group to
5.1 6 1.0 cm H2O in the Con40 group (Table 1). No significant
differences in IPP were found between the Con25 and HA25
groups or between the Con40 and the HA40 groups (Table 1).
Although the transcapillary ultrafiltration rate (Qu) between three
minutes and 240 minutes of the dwell was higher in the Con40
group (0.024 6 0.004 ml/min) as compared to the Con25 group
(0.017 6 0.004 ml/min, P , 0.01; Table 1), the net ultrafiltration
volume was significantly lower (P , 0.01) in the Con40 group as
compared to the Con25 group (Fig. 1 and Table 1), which was due
to a significantly higher peritoneal fluid absorption rate (as
assessed by the RISA elimination rate, KE; Fig. 2 and Table 1).
The KE values were significantly lower in the two hyaluronan
groups as compared to their respective control group, that is
between the HA25 group versus the Con25 group (P , 0.05) and
between the HA40 group versus the Con40 group (P , 0.01;
Table 1 and Fig. 2). Therefore, the ultrafiltration volume was
significantly higher in the two hyaluronan groups as compared to
their respective control groups (Table 1 and Fig. 1). There was no
significant difference in the direct lymphatic absorption as as-
sessed by KEB among the four groups (Table 1 and Fig. 2), and
thus the differences in KE between the groups were mainly due to
the differences in fluid absorption to the adjacent peritoneal
tissue as assessed by KET (Fig. 2).
Glucose transport
Although the diffusive mass transport coefficient for glucose
did not differ among the four groups (Table 2), the D/D0 of
glucose decreased markedly slower in the Con40 group as com-
pared to the Con25 group (Fig. 3). However, the total absorbed
amount of glucose during the dwell was significantly higher with
high fill volumes than with low fill volumes (Fig. 3). The D/D0 was
initially lower and the total absorbed amount of glucose was
initially higher (only at 15 min and 30 min of the dwell) in the
HA25 group compared to the Con25 group (Fig. 3; P , 0.05).
After 30 minutes of the dwell, D/D0 as well as the total absorbed
amount of glucose were not significantly different between the
two groups. The D/D0 of glucose also tended to be lower in the
HA40 group as compared to the Con 40 group, although no
statistical difference was found between the two groups (Fig. 3).
Transport of other solutes
The D/P for urea and protein were significantly lower in the
Con40 group as compared to the Con25 group (Fig. 4; P , 0.05).
There were no significant differences in D/P of urea between the
Con25 and the HA25 groups or between the Con40 and the HA40
groups (Fig. 4). There were no significant differences in KBD
values for urea and for protein between the Con25 and Con40
groups as well as between the two hyaluronan groups and their
respective control groups (Table 2). The urea clearance was
significantly higher in the two high volume groups (Con40 and
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Fig. 1. Changes in intraperitoneal volume (net ultrafiltration) versus
time. Symbols are: (M) 25 ml control group (Con25, N 5 6); (E) 40 ml
control group (Con40, N 5 7); (f) 25 ml with 0.01% hyaluronan group
(HA25, N 5 6); (F) 40 ml with 0.01% hyaluronan group (HA40, N 5 7).
Data are mean 6 SD. Significant differences (P , 0.05) were found
between the Con40 and Con25 groups, between the HA25 and Con25
groups and between the HA40 and Con40 groups (Two-way ANOVA for
repeated measures).
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Fig. 2. The 131I-human serum albumin (RISA) elimination rate from the
peritoneal cavity. Abbreviations are: KE, total RISA elimination rate
representing the fluid absorption rate from the peritoneal cavity; KEB,
RISA elimination rate to the blood from the peritoneal cavity represent-
ing the peritoneal lymphatic absorption; KET, RISA elimination rate to
peritoneal tissue. Symbols are: (M) 25 ml control group (Con25); (f) 25
ml with 0.01% hyaluronan group (HA25); _, 40 ml control group (Con40);
p, 40 ml with 0.01% hyaluronan group (HA40). Data are mean 6 SD.
Significant differences are marked: **P , 0.01 compared to their respec-
tive control groups, that is, between the Con40 and Con25 groups,
between the HA25 and Con25 groups and between the HA40 and Con40
groups.
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HA40) as compared to the two low volume groups (Con25 and
HA25; Table 2). The addition of hyaluronan resulted in signifi-
cantly higher urea clearance as compared to their respective
control groups (Table 2). The dialysate protein concentration was
significantly higher during the dwell in the two hyaluronan groups
as compared to the control groups of the same volume, resulting
in significantly higher (P , 0.05) D/P of protein in the two
hyaluronan groups as compared to the respective control groups
(Fig. 4). This was due to a markedly higher protein appearance in
the dialysate during the initial three minutes of the dwell. There
was no significant difference in the protein clearance among these
four groups when estimated for the period between three minutes
and 240 minutes (Table 2).
DISCUSSION
The present study shows that increased peritoneal dialysate fill
volume of 1.36% glucose dialysis fluid results in decreased net fluid
removal because of increased peritoneal fluid absorption. The
addition of hyaluronan to the dialysis solution significantly in-
creased the net fluid removal by reducing the peritoneal fluid
absorption, and could thus prevent the decrease in net fluid
removal associated with the higher fill volume of 1.36% glucose
dialysis solution.
Effect of increased peritoneal fill volume
Peritoneal fluid absorption is mainly driven by the intraperito-
neal hydrostatic pressure (IPP) [9, 33, 34]. The increased perito-
neal fluid absorption rate associated with the increased IPP due to
the higher intraperitoneal fill volume in the present study is in
agreement with previous studies [3, 8, 9]. However, our results
show that direct lymphatic absorption assessed as the rate of
appearance of intraperitoneally administered macromolecules
(that is, RISA) in the blood (KEB) was not significantly increased
with increases in fill volume (Table 1 and Fig. 2). A similar finding
was reported in previous studies [3, 8, 9]. Therefore, the increase
in peritoneal fluid absorption rate associated with higher fill
volume was mainly due to increased fluid absorption rate into the
adjacent tissues of the peritoneal cavity as assessed by KET.
Although the KE was significantly higher in the Con40 group as
compared to the Con25 group, the transcapillary ultrafiltration
rate (Qu) was also significantly higher in the Con40 group. This is
in agreement with our previous study using 3.86% glucose solu-
tion [3]. The increase in Qu was mainly due to a better mainte-
nance of the glucose concentration gradient in the high fill volume
groups (Fig. 3), in agreement with previous studies [2, 3, 13]. It is
important to note that despite a higher transcapillary ultrafiltra-
tion rate in the higher fill volume groups, the net ultrafiltration
volume was still significantly lower in the Con40 group (24.2 6
1.3 ml) than in the Con25 group (22.3 6 2.3 ml). This was due to
the fact that the increased Qu could not fully compensate for the
increased KE in the Con40 group when using 1.36% glucose
dialysis solution. A similar finding was reported by Krediet et al,
who found that the net ultrafiltration using 1.36% glucose dialysis
solution was significantly lower when using 3 liters of fill volume
compared to 2 liters of fill volume during a four-hour dwell study
in CAPD patients, mainly due to increased peritoneal fluid
absorption in the 3 liter solution group [13]. However, in a
previous study in rats, we found that increases in dialysate fill
volume using 3.86% glucose dialysis solution results in a higher
net ultrafiltration despite a higher peritoneal fluid absorption rate,
Table 1. Fluid transport parameters and intraperitoneal hydrostatic pressure among the four groups (mean 6 SD)
N
IPP
cm H2O
Qu3-240min
ml/min
Net UF
ml
KE KEB KET
ml/min
Con25 6 1.7 6 0.5 16.7 6 4.4 22.3 6 2.3 33.2 6 8.7 5.3 6 1.8 27.8 6 7.1
HA25 6 1.7 6 0.3 16.0 6 1.6 20.3 6 0.3b 25.8 6 2.6b 5.8 6 1.9 20.0 6 2.4b
Con40 7 5.1 6 1.0a 23.7 6 3.7a 24.2 6 1.3b 51.8 6 4.3b 6.1 6 0.4 45.7 6 4.0b
HA40 7 5.2 6 0.9a 20.6 6 2.6a 21.9 6 1.3 36.7 6 5.2c 6.8 6 0.7 29.9 6 5.2c
Abbreviations are: IPP, intraperitoneal hydrostatic pressure after infusion; Qu3-240min, mean transcapillary ultrafiltration rate between 3 min and 240
min; Net UF, net ultrafiltration volume at 4 hour of the dwell; KE, total RISA elimination rate representing the fluid absorption rate from the peritoneal
cavity; KEB, RISA elimination rate to the blood from the peritoneal cavity representing the peritoneal lymphatic absorption; EET, RISA elimination rate
to peritoneal tissue.
a P , 0.01 compared to the groups with the lower fill volume
b P , 0.05 compared to the Con25 group
c P , 0.01 compared to the Con40 group
Table 2. Diffusive mass transport coefficients, KBD (ml/min), for glucose, urea, and total protein as well as peritoneal clearances, ml/min, for urea
and total protein (mean 6 SD)
N
KBD ml/min Peritoneal clearance ml/min
Glucose Urea Total protein Urea Total proteind
Con25 6 0.24 6 0.09 0.27 6 0.10 0.003 6 0.002 78 6 4 3.2 6 1.1
HA25 6 0.28 6 0.05 0.29 6 0.06 0.004 6 0.002 94 6 6a 3.2 6 1.2
Con40 7 0.23 6 0.06 0.34 6 0.09 0.003 6 0.001 123 6 6b 3.0 6 1.5
HA40 7 0.29 6 0.04 0.43 6 0.12 0.003 6 0.001 143 6 17c 3.4 6 1.2
a P , 0.05 compared with the Con25 groups
b P , 0.01 compared with the Con25 group
c P , 0.01 compared with the Con40 group
d calculated for the time period 3–240 min
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which was due to a higher Qu with the 3.86% glucose solution
counterbalancing the increase in KE [3]. Therefore, we conclude
that a decreased net ultrafiltration volume associated with higher
dialysate fill volume (due to higher IPP and higher peritoneal fluid
absorption) can be avoided if hypertonic glucose solutions are
used.
Effect of hyaluronan on fluid transport
The significant decrease in KE in the HA25 and HA40 groups
compared to their respective control groups is in accordance with
our findings in a previous study showing that an addition of
hyaluronan to the dialysis fluid could markedly reduce peritoneal
fluid absorption [23]. In the previous study, we speculated that the
observed effect of hyaluronan on peritoneal fluid absorption may
be due both to the accumulation of a restrictive filter “cake” of
hyaluronan chains at the tissue-cavity interface [23] as well as to a
stabilizing effect on endogenous hyaluronan at the mesothelial
cell surface [35]. It is interesting to note that in the present study
the magnitude of the decrease in peritoneal fluid absorption was
much higher when the higher fill volume was used. The difference
(0.15 ml/min) in KE between the Con40 and the HA40 groups was
much higher than the difference (0.07 ml/min) in KE between the
Con25 and the HA25 groups. As peritoneal fluid absorption is
mainly driven by IPP, it is possible that raising IPP may transiently
increase convective transport into the boundary, thereby raising
the concentration and thickness of the hyaluronan layer, which
could increase the resistance to the outflow of fluid from the
peritoneal cavity. These results are similar to the observation
made by McDonald and Levick, who found that an increase in the
intra-articular pressure significantly increase the resistance of
fluid outflow from the joint [36], the fluid outflow rate (from the
joint) was in fact even lower when a significantly higher pressure
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Fig. 3. Dialysate glucose concentration (D) to fresh dialysate glucose
concentration (D0) ratio (A) and total absorbed amount of glucose (B)
versus dwell time. Symbols are: (M) 25 ml control group (Con25, N 5 6);
(E) 40 ml control group (Con40, N 5 7); (f) 25 ml with 0.01% hyaluronan
group (HA25, N 5 6); (F) 40 ml with 0.01% hyaluronan group (HA40,
N 5 7). Significant differences (P , 0.05) were found between the Con40
group and the Con25 group for both D/D0 and the total absorbed amount
of glucose. The D/D0 was significantly lower and the total absorbed
amount of glucose was significantly higher in the HA25 group at 15 and 30
minutes of the dwell compared to the Con25 group.
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Fig. 4. Dialysate to plasma concentration ratio (D/P) for urea (A) and
total protein (B) versus dwell time. Symbols are: (M) 25 ml control group
(Con25, N 5 6); (E) 40 ml control group (Con40, N 5 7); (f) 25 ml with
0.01% hyaluronan group (HA25, N 5 6); (F) 40 ml with 0.01% hyaluro-
nan group (HA40, N 5 7). Significant differences (P , 0.05) were found
for total protein between the Con25 and Con40 groups as well as between
the two hyaluronan groups and their respective control groups.
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was induced compared to the outflow rate observed under low
intra-articular pressure [36]. Under electron microscopy, they also
observed that a hyaluronan membrane was formed at the tissue-
cavity interface [36]. In the present study, the difference in
peritoneal fluid absorption rate between the two hyaluronan
groups and their respective control groups was almost entirely due
to the difference in the fluid absorption rate to adjacent perito-
neal tissues as assessed by KET, suggesting a specific effect of
hyaluronan on KET (and not KEB). The similar KE between the
Con25 and the HA40 groups in our study suggests that intraperi-
toneal addition of hyaluronan could prevent the decreased net
ultrafiltration volume associated with higher dialysate fill volume
of 1.36% glucose solution.
Solute transport
The significantly slower decrease in dialysate glucose concen-
tration (as reflected by D/D0) as well as lower D/P of urea and
total protein in the Con40 group compared to the Con25 group
are in agreement with our previous study [3]. This is a result of the
principle governed by the geometry of diffusion stating that
equilibration of a solute occurs rapidly when the dialyzed solute
diffuses into or from a relatively small volume, whereas relatively
slower equilibration occurs in association with diffusion into a
larger volume. As the diffusive mass transport coefficients (KBD)
for glucose and urea did not significantly increase with the
increase in fill volume, the rate of maximal diffusive transport (as
estimated by KBD) to the volume that should be cleared (fill
volume) decreased with high dialysate volume, resulting in a
slower decrease in the dialysate glucose concentration as well as in
lower D/P of urea.
Glucose absorption was unexpectedly slightly enhanced in the
two hyaluronan groups during the initial part of the dwell, which
is similar to our previous observation [23]. The mechanism is not
clear. However, it has been reported that the diffusion of glucose
in a matrix gel containing hyaluronan was significantly increased
[37]. Hadler suggested that this increased diffusivity might be due
to the interaction between glucose and the hyaluronan domain
that facilitates glucose movement [38]. However, further studies
are needed to elucidate the mechanism(s) of the transiently
increase in glucose absorption induced by the addition of hyalu-
ronan to the dialysate.
The total protein concentrations in dialysate in the two hyalu-
ronan groups were higher during the whole dwell as compared to
their respective control groups. It is unlikely that the higher
protein concentration was due to an increased transport of
protein from the blood, as the difference in protein appearance in
dialysate was observed during the initial three minutes only. In
separate experiments, we did not find any significant difference in
white blood cell counts in the effluents by adding hyaluronan to
the dialysis fluid as compared to the control solution, suggesting
that adding hyaluronan to the dialysate did not induce local
inflammation. In addition, hyaluronan is an effective anti-inflam-
mation substance, and it has been shown that hyaluronan could
inhibit acute and chronic inflammation [39]. The accuracy of the
protein analytical assay was found to be unaffected by the
presence of 0.01% hyaluronan in vitro (data not shown). There
was no significant increase in protein clearance in the HA groups
in our study as estimated from three minutes, which is in
agreement with previous observations [3]. Therefore, we specu-
late that the rapid increase in protein concentration found during
the initial three minutes of the dwell may be due to a competition
of hyaluronan with surface proteins for binding onto the mesothe-
lial cell surface.
The significant increase in urea clearance in the high fill volume
groups is not unexpected. However, it is important to note that
adequacy of dialysis is not only a matter of removing enough small
solutes, but also a matter a removing enough fluid [40, 41]. In fact,
inadequate fluid removal and inadequate blood pressure control
are common in CAPD patients [42, 43], and may contribute to
cardiovascular disease, which is the main cause of death in PD
patients [43]. Therefore, if the increase in urea clearance with
high dialysate fill volume is associated with a decrease in net fluid
removal, this represents an important clinical problem. The
addition of hyaluronan to dialysate may be a way to overcome this
problem, as the addition of hyaluronan resulted in both increased
fluid removal and increased urea clearances.
In summary, our results suggest that (1) An increase in dialysate
fill volume using 1.36% glucose dialysis solution results in higher
intraperitoneal hydrostatic pressure and higher peritoneal fluid
absorption rate, and therefore in fact results in lower net ultrafil-
tration despite a higher transcapillary ultrafiltration rate. (2)
Intraperitoneal addition of hyaluronan significantly decreases the
peritoneal fluid absorption rate. The decreasing effect was more
significant when high fill volume was used, reflecting perhaps a
possible formation of a “hyaluronan filter cake” at the peritoneal
cavity-tissue interface. (3) In general, the peritoneal diffusive
mass transport coefficients did not change with different fill
volume or by adding hyaluronan; however, small solute clearances
increase markedly with increases in fill volume and by adding
hyaluronan to the dialysate due to the higher drainage volume.
ACKNOWLEDGMENTS
This study was supported by a grant from Baxter Healthcare Corpora-
tion, McGaw Park, Illinois, USA. We thank Dr. Torvard C. Laurent for
support and constructive criticism of this work, and Ms. Monica Eriksson
for technical assistance.
Reprint requests to Dr. B. Lindholm, Divisions of Baxter Novum and Renal
Medicine K-56, Huddinge University Hospital, Karolinska Institute, S-141 86
Huddinge, Sweden.
APPENDIX
Abbreviations used in this paper are: IPP, intraperitoneal hydrostatic
pressure; Con25 and Con40, control groups with 25 ml and 40 ml glucose
injection, respectively; HA25 and HA40, groups with 25 ml or 40 ml
glucose 1 hyaluronan injection, respectively; RISA, 131I-human serum
albumin; KE, rate of fluid absorption; Vt, intraperitoneal volume at time t;
V0, infused volume; Qu, transcapillary ultrafiltration rate; KEB, elimination
rate from the peritoneal cavity to the blood; KET, fluid absorption to the
peritoneal tissue interstitium and capillaries; D/P, dialysate-to-plasma-
solute concentration ratio; D/D0, dialysate glucose concentration divided
by the glucose concentration in fresh dialysate; KBD, diffusive mass
transport coefficient.
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